Small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) is a rare and distinct ovarian malignancy that requires a specific clinical approach. This page outlines the key considerations and links to the full structured protocol.
This protocol applies to patients diagnosed with small cell carcinoma of the ovary, hypercalcemic type (SCCOHT) — a rare ovarian cancer subtype with characteristic clinical and molecular features. Germline status, particularly with respect to SMARCA4, is a key factor shaping the surgical and management approach.
The primary intervention is surgical, with the scope of the procedure determined by clinical findings and germline testing results. Under specific circumstances, a more limited surgical option may be considered after appropriate counseling.